Surprisingly, early-stage CTE showed no link to cognitive decline In A Nutshell CTE severity had no link to depression, ...
A major new study has found that transcranial magnetic stimulation (TMS), which applies magnetic energy to the brain, can be a cost-effective ...
Clinical Trials Arena on MSN
Axsome begins Phase III AXS-14 FORWARD trial for fibromyalgia management
The study consists of an open-label AXS-14 treatment period followed by a randomised, double-blind treatment period.
GlobalData on MSN
Lipocine completes Phase III enrolment for LPCN 1154 in PPD
Lipocine expects trial data to support a 505(b)(2) new drug application submission for LPCN 1154 in 2026.
FloGrappling on MSN
Cresencio Zamora III vs James Aglubat 2026 Arte Suave 5th anniversary event
Cresencio Zamora III vs James Aglubat 2026 Arte Suave 5th Anniversary Event ...
When modern political debate turns to questions of instability, irrationality, and fitness to govern, George III functions as ...
The FDA has approved the first prescription, at-home neuromodulation therapy for individuals with major depressive disorder ...
Higher BMI is linked to worse PROMIS profiles and increased opioid use among patients seeking spine care, despite similar pain intensity across BMIs.
FOX 5 DC on MSN
Martin Luther King III reflects on father's legacy
Martin Luther King III, son of Dr. Martin Luther King Jr. and Coretta Scott King, shares his thoughts on the legacy of his ...
The FDA has approved ProlivRx, the first prescription, home-based brain neuromodulation therapy, as an adjunctive treatment ...
Ruger has announced the return of one of America's most iconic over/under shotguns with the Red Label III. First launched in 1977, the original Ruger Red Label earned a reputation for rugged ...
It’s the Old Major here with some more of those thoughts that wander through Kitsap County and occasionally beyond. “These ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results